tiprankstipranks
Trending News
More News >
Diatreme Resources Limited (AU:DRX)
ASX:DRX
Australian Market

Diatreme Resources Limited (DRX) AI Stock Analysis

Compare
2 Followers

Top Page

AU:DRX

Diatreme Resources Limited

(Sydney:DRX)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
AU$0.02
▼(-10.00% Downside)
The overall stock score is primarily influenced by financial performance challenges, particularly in profitability and cash flow management. Technical analysis indicates a lack of momentum, and the absence of valuation metrics further limits the stock's attractiveness.
Positive Factors
Balance Sheet Strength
Conservative leverage and a high equity ratio provide durable financial flexibility for a junior explorer. This reduces refinancing and solvency risk during prolonged project development cycles, supporting ability to fund exploration or secure partner joint ventures over months.
Improving Revenue Trend
Material year-over-year revenue growth signals early commercial traction, validating project-market fit for silica products. Sustained top-line improvement can underpin scale-up, justify additional investment, and help transition toward positive cash generation if sustained over subsequent quarters.
Focused Asset Strategy
A clear flagship (Clermont Silica) and concentration on silica/rare earths gives strategic focus. Targeting established industrial end-markets (glass, construction) improves off-take and commercialization prospects, enabling durable pathway from exploration to revenue if project milestones are met.
Negative Factors
Negative Cash Flow
Persistent negative operating and free cash flows create structural funding pressure for a development-focused miner. Continued cash burn raises reliance on external financing, increasing dilution and execution risk, and may constrain sustained project development absent stronger cash generation.
Sustained Profitability Deficit
Ongoing negative EBIT/EBITDA margins indicate that operations are not yet economically self-sustaining. Without clear margin improvement through cost control, scale or higher-margin product mix, the company risks prolonged losses that impair return on invested capital and investor support.
Limited Operational Scale
A very small headcount constrains internal execution capacity for exploration, permitting and project development. Reliance on contractors or partners increases coordination risk and may slow project delivery, making timely advancement to production and revenue scaling more uncertain.

Diatreme Resources Limited (DRX) vs. iShares MSCI Australia ETF (EWA)

Diatreme Resources Limited Business Overview & Revenue Model

Company DescriptionDiatreme Resources Limited engages in the exploration of heavy mineral sands, copper, gold, and base metals in Australia. The company's flagship property is the Galalar Silica Sand project located in North Queensland. Diatreme Resources Limited was incorporated in 1993 and is based in Coorparoo, Australia.
How the Company Makes MoneyDiatreme Resources Limited generates revenue primarily through the exploration and potential development of its mineral projects, particularly in silica and rare earth elements. The company's revenue model is based on the sale of extracted mineral products once the projects reach production stage. Key revenue streams include the sale of silica products to industries such as glass manufacturing, construction, and other industrial applications. The company may also engage in partnerships or joint ventures with other mining firms to enhance its exploration capabilities and share development costs. Additionally, Diatreme could benefit from securing off-take agreements with buyers, ensuring a steady demand for its products once production commences.

Diatreme Resources Limited Financial Statement Overview

Summary
Diatreme Resources Limited shows revenue growth but struggles with profitability, as evidenced by negative EBIT and EBITDA margins. The balance sheet is strong with low leverage, but cash flow issues persist, with negative operating and free cash flows.
Income Statement
45
Neutral
Diatreme Resources Limited has demonstrated volatile revenue growth, with a recent increase to $886,464 from $468,506 in 2023, indicating a significant positive trend. However, the company has consistently reported negative EBIT and EBITDA margins, reflecting operational challenges. The net profit margin has also been negative for most years, suggesting ongoing profitability issues.
Balance Sheet
60
Neutral
The company maintains a strong equity base with a high equity ratio due to substantial stockholders' equity compared to total assets. The debt-to-equity ratio is relatively low, indicating conservative leverage. However, the return on equity has been inconsistent due to fluctuating net income, posing potential concerns regarding equity efficiency.
Cash Flow
40
Negative
Cash flow analysis reveals negative operating cash flow and free cash flow, indicating cash generation challenges. The free cash flow to net income ratio is unfavorable, highlighting inefficiencies. Nevertheless, the company has managed to secure financing to support its operations, though this may not be sustainable long-term.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.00M886.46K468.51K110.14K23.94K21.28K
Gross Profit1.00M886.46K254.29K-61.14K-77.02K-50.22K
EBITDA-3.76M-4.61M10.70M-2.94M-1.94M-795.89K
Net Income45.75K-439.53K10.37M4.98M-2.15M-1.04M
Balance Sheet
Total Assets94.61M95.45M66.53M55.33M33.14M25.62M
Cash, Cash Equivalents and Short-Term Investments3.82M5.19M10.77M13.64M6.50M5.79M
Total Debt1.17M1.20M1.75M1.54M1.61M1.64M
Total Liabilities2.33M2.51M2.96M2.59M2.37M2.40M
Stockholders Equity92.27M92.94M63.57M52.75M30.76M23.22M
Cash Flow
Free Cash Flow-5.35M-7.71M-2.80M-9.57M-8.70M-4.24M
Operating Cash Flow-3.55M-6.00M-2.32M-2.51M-2.15M-1.14M
Investing Cash Flow-1.80M1.06M-462.49K-6.95M-6.57M-2.33M
Financing Cash Flow-139.71K-643.79K-86.47K16.60M9.43M6.77M

Diatreme Resources Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
200.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DRX, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 200.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DRX.

Diatreme Resources Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
51
Neutral
AU$353.53M-16.37-140.97%
46
Neutral
AU$79.40M-35.45-9.27%35.29%
46
Neutral
AU$90.15M-0.27%-100.00%
44
Neutral
AU$490.17M-6.67-84.61%149.43%1.20%
44
Neutral
AU$125.71M-6.58-21.39%-280.00%
43
Neutral
AU$201.04M-5.46-12.73%2.00%8.82%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DRX
Diatreme Resources Limited
0.02
>-0.01
-14.29%
AU:A1G
African Gold Ltd.
0.64
0.58
976.27%
AU:EQR
EQ Resources Limited
0.11
0.07
182.05%
AU:ASM
Australian Strategic Materials Ltd
0.74
0.25
51.02%
AU:FHE
Frontier Energy Limited
0.23
0.11
87.50%
AU:ESR
Estrella Resources Limited
0.04
0.02
62.50%

Diatreme Resources Limited Corporate Events

Diatreme Resources Advances Northern Silica Project with DEIS Submission
Dec 14, 2025

Diatreme Resources Limited has submitted the Draft Environmental Impact Statement (DEIS) for its Northern Silica Project to Queensland’s Office of the Coordinator-General. This submission marks a significant milestone in the project’s approval process, highlighting its potential to deliver economic benefits and support the clean energy transition. The DEIS, prepared after extensive investigations, outlines the project’s scope, potential impacts, and mitigation strategies, paving the way for public consultation and review in 2026. The project promises new employment and investment opportunities for the Hope Vale/Cooktown region while managing environmental and cultural impacts.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources’ Stake in Moonlight Resources Debuts on ASX
Dec 11, 2025

Diatreme Resources Limited announced that Moonlight Resources Ltd, where it holds a 16.8% stake, has been listed on the Australian Securities Exchange. This follows Moonlight’s acquisition of Chalcophile Resources Pty Ltd and PGE Minerals Pty Ltd, which own the Clermont Gold Project. Moonlight has commenced drilling at the project, aiming for a Mineral Resource Estimate with results expected in Q1 2026. The IPO raised A$10 million, with Diatreme receiving shares and cash, and retaining the right to appoint a director to Moonlight’s board.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources Finalizes Sale of Clermont Gold Project
Dec 5, 2025

Diatreme Resources Limited has completed the sale of its Clermont Gold Project to Moonlight Resources Limited, receiving $3.25 million in Moonlight shares and $250,000 in cash. This transaction makes Diatreme a significant shareholder in Moonlight, with the right to appoint a director to Moonlight’s board, and it aligns with Moonlight’s upcoming IPO and ASX listing.

The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.

Diatreme Resources Maintains Steady Production Targets Amidst Global Silica Demand
Nov 13, 2025

Diatreme Resources Limited announced that their resource estimates and production targets remain unchanged as of June 2025, with no new information affecting previous announcements. The company emphasizes the importance of securing project development finance and attracting financial partners to meet production targets, highlighting the ongoing demand for high purity silica sand in the market.

Diatreme Resources Director Acquires Significant Shareholding
Nov 11, 2025

Diatreme Resources Limited announced a change in the director’s interest, with Karalyn Keys acquiring 2,546,253 ordinary shares through an on-market trade. This acquisition reflects a significant investment in the company, potentially indicating confidence in its future prospects and impacting its market positioning.

Diatreme Resources Announces Director’s Share Disposal
Oct 31, 2025

Diatreme Resources Limited announced a change in the director’s interest, specifically involving the disposal of 2,819,640 ordinary shares held indirectly by the director through a family member. This transaction, valued at $53,573, reflects a shift in the director’s investment position but does not alter the director’s holdings of unquoted options, which remain unchanged. The announcement may influence stakeholders’ perceptions of the company’s internal governance and director confidence.

Diatreme Resources Announces Shareholder Priority Offer in Moonlight IPO
Oct 29, 2025

Diatreme Resources Limited announced a corrected header for their shareholders’ priority offer in the Moonlight Resources IPO Prospectus. The offer, fully underwritten at $3.0 million, allows DRX shareholders to purchase Moonlight shares at $0.20 each, with an additional free option for every two shares acquired. This move follows Diatreme’s agreement to sell its shares in Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited to Moonlight, receiving 16,250,000 Moonlight shares and $250,000 in cash. This transaction is expected to enhance Diatreme’s financial position and provide its shareholders with strategic investment opportunities.

Diatreme Sells Clermont Project to Focus on Silica Assets
Oct 29, 2025

Diatreme Resources Ltd has entered into a Share Sale Agreement with Moonlight Resources Limited to sell all outstanding shares in its subsidiaries, Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited, which own the Clermont Project. As part of the transaction, Diatreme will receive 16,250,000 ordinary shares in Moonlight valued at $3,250,000 and a cash payment of A$250,000. Additionally, Diatreme shareholders are offered a priority share offer in Moonlight’s IPO, with incentives for participation. This move allows Diatreme to focus on its core silica assets while retaining an interest in the future development of the Clermont Project.

Lithium Plus Expands Gold Exposure Through Moonlight Resources Acquisition
Oct 29, 2025

Lithium Plus Minerals Ltd, a company focused on advancing its lithium portfolio and the Lei Development Project, announced that its 33.5% owned entity, Moonlight Resources Limited, has entered into a Share Sale Agreement with Diatreme Resources Ltd to acquire Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited, which own the Clermont Gold Project. This acquisition provides Lithium Plus shareholders with exposure to gold assets while maintaining the company’s focus on lithium. Moonlight is offering a fully underwritten Priority Offer to Lithium Plus shareholders, allowing them to purchase shares at a discounted price with additional options, enhancing shareholder value and positioning Moonlight for future growth.

Diatreme Resources Advances Silica Project Amid Financial Improvements
Oct 28, 2025

Diatreme Resources Limited announced significant progress in its Northern Silica Project, receiving Major Project Status and advancing its Environmental Impact Statement to the final approval stages. The company reported a reduced net loss for the half year and secured a government tax rebate for its Cyclone Zircon Project. Diatreme maintains a strong cash position, with a total of $10.71 million, and continues to engage with investors through conferences and presentations.

Diatreme Resources Reports Enhanced Mineral Recoveries at Cyclone Project
Oct 23, 2025

Diatreme Resources Limited announced significant advancements in metallurgical testwork on its Cyclone project, showing improved recoveries of heavy minerals, zirconium dioxide, and titanium dioxide. The testwork, conducted by Mineral Technologies, aims to enhance mineral recoveries and optimize processing, potentially increasing shareholder value. The results, expected by November 2025, will inform the design of an improved processing flowsheet, with samples provided to potential customers for evaluation.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025